Tag: FBDD
Fragment-based design of isoquinoline derivatives as anti-inflammatory drugs

Fragment-based drug discovery (FBDD) is a well-established high-throughput screening method for drug generation. Fragment molecules used in FBDD tend to be structurally less complex than the compounds used in conventional high-throughput screening techniques. Dr Masakazu Atobe from Asahi Kasei Pharma Corporation in Japan and his colleagues have developed a methodology that can be applied to the discovery of effective drugs […]
Read More… from Fragment-based design of isoquinoline derivatives as anti-inflammatory drugs